Pioglitazone has a dubious bladder cancer risk but an undoubted cardiovascular benefit

Publisher: John Wiley & Sons Inc

E-ISSN: 1464-5491|32|3|305-313

ISSN: 0742-3071

Source: DIABETIC MEDICINE, Vol.32, Iss.3, 2015-03, pp. : 305-313

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract